Neuropeptide Y, peptide YY and pancreatic polypeptide in the gut-brain axis

Neuropeptides

Volumn 46, Issue 6, 2012, Pages 261-274

  Holzer, Peter ^a   Reichmann, Florian ^a   Farzi, Aitak ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Anxiety; Cytokines; Depression; Food intake; Gut hormones; Gut brain axis; Immune system; Inflammation; Neuropeptide Y; Pain; Pancreatic polypeptide; Peptide YY; Satiety; Stress resilience; Visceral hyperalgesia

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; ADENOSINE TRIPHOSPHATE; AGOUTI RELATED PROTEIN; ANTIBIOTIC AGENT; CHOLECYSTOKININ; CYTOKINE RECEPTOR ANTAGONIST; DEXTRAN SULFATE; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; GASTROINTESTINAL HORMONE; GLICENTIN; GUANINE NUCLEOTIDE BINDING PROTEIN; GUSTDUCIN; INTERLEUKIN 12; NEURONAL NITRIC OXIDE SYNTHASE; NEUROPEPTIDE Y; NEUROPEPTIDE Y RECEPTOR; NEUROPEPTIDE Y1 RECEPTOR; NEUROPEPTIDE Y2 RECEPTOR; NEUROPEPTIDE Y4 RECEPTOR; NEUROPEPTIDE Y5 RECEPTOR; NORADRENALIN; PANCREAS POLYPEPTIDE; PEPTIDE YY; PEPTIDE YY [3-36]; PROBIOTIC AGENT; RECOMBINANT INTERLEUKIN 1BETA; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; SHORT CHAIN FATTY ACID; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UNINDEXED DRUG;

AMINO TERMINAL SEQUENCE; AMYGDALOID NUCLEUS; ANTIDEPRESSANT ACTIVITY; ANXIETY; ANXIETY DISORDER; APPETITE; ATTENUATION; BACTERIAL COLONIZATION; BEHAVIOR DISORDER; BRAIN; BRAIN STEM; CELL DIFFERENTIATION; CYTOKINE PRODUCTION; DEPRESSION; DIGESTIVE SYSTEM; DIGESTIVE SYSTEM INFLAMMATION; EMOTIONALITY; ENERGY CONSUMPTION; FOOD INTAKE; GASTROINTESTINAL MOTILITY; GROWTH INHIBITION; HOMEOSTASIS; HUMAN; HYPOTHALAMUS; IMMUNE SYSTEM; INTESTINE; INTESTINE FLORA; MEDIATOR; MOOD; NEUROENDOCRINE SYSTEM; NEUROSECRETORY CELL; NOCICEPTION; NONHUMAN; PANCREAS; PARASYMPATHETIC NERVE CELL; PEPTIDE SYNTHESIS; PERISTALSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SECRETION; REVIEW; SENSORY NERVE CELL; SIGNAL TRANSDUCTION; SPINAL CORD; STOMACH ACID; STOMACH ACID SECRETION; SYMPATHETIC NERVE CELL; THALAMUS; TRANQUILIZING ACTIVITY; VASOCONSTRICTION;

ANIMALS; BRAIN; GASTROINTESTINAL HORMONES; GASTROINTESTINAL TRACT; HOMEOSTASIS; HUMANS; IMMUNE SYSTEM; NEUROPEPTIDE Y; PANCREATIC POLYPEPTIDE; PEPTIDE YY; SIGNAL TRANSDUCTION;

EID: 84869878192     PISSN: 01434179     EISSN: 15322785     Source Type: Journal    
DOI: 10.1016/j.npep.2012.08.005     Document Type: Review

References (216)

1. Acuna-Goycolea C., Tamamaki N., Yanagawa Y., Obata K., van den Pol A.N. Mechanisms of neuropeptide Y, peptide YY, and pancreatic polypeptide inhibition of identified green fluorescent protein-expressing GABA neurons in the hypothalamic neuroendocrine arcuate nucleus. J. Neurosci. 2005, 25:7406-7419.
2. Adrian T.E., Savage A.P., Bacarese-Hamilton A.J., Wolfe K., Besterman H.S., Bloom S.R. Peptide YY abnormalities in gastrointestinal diseases. Gastroenterology 1986, 90:379-384.
3. Ahlman H., Nilsson O. The gut as the largest endocrine organ in the body. Ann. Oncol. 2001, 12(Suppl. 2):S63-S68.
4. Alexander S.P.H., Mathie A., Peters J.A. Guide to receptors and channels (GRAC), 5th ed. Br. J. Pharmacol. 2011, 164(Suppl. 1):S1-S324.
5. Allen Y.S., Adrian T.E., Allen J.M., Tatemoto K., Crow T.J., Bloom S.R. Neuropeptide Y distribution in the rat brain. Science 1983, 221:877-879.
6. Anisman H., Merali Z., Poulter M.O., Hayley S. Cytokines as a precipitant of depressive illness: Animal and human studies. Curr. Pharm. Des. 2005, 11:963-972.
7. Asakawa A., Inui A., Ueno N., Fujimiya M., Fujino M.A., Kasuga M. Mouse pancreatic polypeptide modulates food intake, while not influencing anxiety in mice. Peptides 1999, 20:1445-1448.
8. Asakawa A., Inui A., Yuzuriha H., Ueno N., Katsuura G., Fujimiya M., Fujino M.A., Niijima A., Meguid M.M., Kasuga M. Characterization of the effects of pancreatic polypeptide in the regulation of energy balance. Gastroenterology 2003, 124:1325-1336.
9. Bacchi F., Mathé A.A., Jimenez P., Stasi L., Arban R., Gerrard P., Caberlotto L. Anxiolytic-like effect of the selective Neuropeptide Y Y2 receptor antagonist BIIE0246 in the elevated plus-maze. Peptides 2006, 27:3202-3207.
10. Ballinger A.B., Williams G., Corder R., El-Haj T., Farthing M.J. Role of hypothalamic neuropeptide Y and orexigenic peptides in anorexia associated with experimental colitis in the rat. Clin. Sci. (Lond.) 2001, 100:221-229.
11. Banks W.A., Kastin A.J., Jaspan J.B. Regional variation in transport of pancreatic polypeptide across the blood-brain barrier of mice. Pharmacol. Biochem. Behav. 1995, 51:139-147.
12. Bannon A.W., Seda J., Carmouche M., Francis J.M., Norman M.H., Karbon B., McCaleb M.L. Behavioral characterization of neuropeptide Y knockout mice. Brain Res. 2000, 868:79-87.
13. Baticic L., Detel D., Kucic N., Buljevic S., Pugel E.P., Varljen J. Neuroimmunomodulative properties of dipeptidyl peptidase IV/CD26 in a TNBS-induced model of colitis in mice. J. Cell. Biochem. 2011, 112:3322-3333.
14. 3-36 physiologically inhibits food intake. Nature 2002, 418:650-654.
15. 3-36. N. Engl. J. Med. 2003, 349:941-948.
16. Batterham R.L., Le Roux C.W., Cohen M.A., Park A.J., Ellis S.M., Patterson M., Frost G.S., Ghatei M.A., Bloom S.R. Pancreatic polypeptide reduces appetite and food intake in humans. J. Clin. Endocrinol. Metab. 2003, 88:3989-3992.
17. Batterham R.L., Ffytche D.H., Rosenthal J.M., Zelaya F.O., Barker G.J., Withers D.J., Williams S.C. PYY modulation of cortical and hypothalamic brain areas predicts feeding behaviour in humans. Nature 2007, 450:106-109.
18. Bedoui S., von Hörsten S., Gebhardt T. A role for neuropeptide Y (NPY) in phagocytosis: Implications for innate and adaptive immunity. Peptides 2007, 28:373-376.
19. Bercik P., Verdu E.F., Foster J.A., Lu J., Scharringa A., Kean I., Wang L., Blennerhassett P., Collins S.M. Role of gut-brain axis in persistent abnormal feeding behavior in mice following eradication of Helicobacter pylori infection. Am. J. Physiol. 2009, 296:R587-R594.
20. Bercik P., Denou E., Collins J., Jackson W., Lu J., Jury J., Deng Y., Blennerhassett P., Macri J., McCoy K.D., Verdu E.F., Collins S.M. The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice. Gastroenterology 2011, 141:599-609.
21. Bercik P., Park A.J., Sinclair D., Khoshdel A., Lu J., Huang X., Deng Y., Blennerhassett P.A., Fahnestock M., Moine D., Berger B., Huizinga J.D., Kunze W., McLean P.G., Bergonzelli G.E., Collins S.M., Verdu E.F. The anxiolytic effect of Bifidobacterium longum NCC3001 involves vagal pathways for gut-brain communication. Neurogastroenterol. Motil. 2011, 23:1132-1139.
22. Bercik P., Collins S.M., Verdu E.F. Microbes and the gut-brain axis. Neurogastroenterol. Motil. 2012, 24:405-413.
23. Berntson G.G., Zipf W.B., O'Dorisio T.M., Hoffman J.A., Chance R.E. Pancreatic polypeptide infusions reduce food intake in Prader-Willi syndrome. Peptides 1993, 14:497-503.
24. Böttcher G., Ekblad E., Ekman R., Håkanson R., Sundler F. Peptide YY: A neuropeptide in the gut. Immunocytochemical and immunochemical evidence. Neuroscience 1993, 55:281-290.
25. Bravo J.A., Forsythe P., Chew M.V., Escaravage E., Savignac H.M., Dinan T.G., Bienenstock J., Cryan J.F. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc. Natl. Acad. Sci. USA 2011, 108:16050-16055.
26. Brumovsky P., Shi T.S., Landry M., Villar M.J., Hökfelt T. Neuropeptide tyrosine and pain. Trends Pharmacol. Sci. 2007, 28:93-102.
27. Campbell R.E., Smith M.S., Allen S.E., Grayson B.E., Ffrench-Mullen J.M., Grove K.L. Orexin neurons express a functional pancreatic polypeptide Y4 receptor. J. Neurosci. 2003, 23:1487-1497.
28. Cani P.D., Delzenne N.M. The gut microbiome as therapeutic target. Pharmacol. Ther. 2011, 130:202-212.
29. Cani P.D., Lecourt E., Dewulf E.M., Sohet F.M., Pachikian B.D., Naslain D., De Backer F., Neyrinck A.M., Delzenne N.M. Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal. Am. J. Clin. Nutr. 2009, 90:1236-1243.
30. 3-36 on food intake and hypothalamic neuropeptide expression in the mouse. Biochem. Biophys. Res. Commun. 2003, 311:915-919.
31. Chandrasekharan B., Bala V., Kolachala V.L., Vijay-Kumar M., Jones D., Gewirtz A.T., Sitaraman S.V., Srinivasan S. Targeted deletion of neuropeptide Y (NPY) modulates experimental colitis. PLoS One 2008, 3:e3304.
32. Chee M.J., Colmers W.F. Y eat?. Nutrition 2008, 24:869-877.
33. Chen C.H., Stephens R.L., Rogers R.C. PYY and NPY: Control of gastric motility via action on Y1 and Y2 receptors in the DVC. Neurogastroenterol. Motil. 1997, 9:109-116.
34. Cherbut C., Ferrier L., Rozé C., Anini Y., Blottière H., Lecannu G., Galmiche J.P. Short-chain fatty acids modify colonic motility through nerves and polypeptide YY release in the rat. Am. J. Physiol. 1998, 275:G1415-G1422.
35. Clarke T.B., Davis K.M., Lysenko E.S., Zhou A.Y., Yu Y., Weiser J.N. Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity. Nat. Med. 2010, 16:228-231.
36. Cohen H., Liu T., Kozlovsky N., Kaplan Z., Zohar J., Mathé A.A. The neuropeptide Y (NPY)-ergic system is associated with behavioral resilience to stress exposure in an animal model of post-traumatic stress disorder. Neuropsychopharmacology 2012, 37:350-363.
37. Cox H.M. Neuropeptide Y receptors; antisecretory control of intestinal epithelial function. Auton. Neurosci. 2007, 133:76-85.
38. Cox H.M. Peptide YY: A neuroendocrine neighbor of note. Peptides 2007, 28:345-351.
39. Cox H.M., Tough I.R. Neuropeptide Y, Y1, Y2 and Y4 receptors mediate Y agonist responses in isolated human colon mucosa. Br. J. Pharmacol. 2002, 135:1505-1512.
40. Cox H.M., Tough I.R., Woolston A.M., Zhang L., Nguyen A.D., Sainsbury A., Herzog H. Peptide YY is critical for acylethanolamine receptor Gpr119-induced activation of gastrointestinal mucosal responses. Cell Metab. 2010, 11:532-542.
41. Dantzer R., O'Connor J.C., Freund G.G., Johnson R.W., Kelley K.W. From inflammation to sickness and depression: When the immune system subjugates the brain. Nat. Rev. Neurosci. 2008, 9:46-56.
42. de Lange R.P., Wiegant V.M., Stam R. Altered neuropeptide Y and neurokinin messenger RNA expression and receptor binding in stress-sensitised rats. Brain Res. 2008, 1212:35-47.
43. Delzenne N.M., Neyrinck A.M., Bäckhed F., Cani P.D. Targeting gut microbiota in obesity: Effects of prebiotics and probiotics. Nat. Rev. Endocrinol. 2011, 7:639-646.
44. DiMaggio D.A., Chronwall B.M., Buchanan K., O'Donohue T.L. Pancreatic polypeptide immunoreactivity in rat brain is actually neuropeptide Y. Neuroscience 1985, 15:1149-1157.
45. Dimitrijević, M., Stanojević, S., in press. The intriguing mission of neuropeptide Y in the immune system. Amino Acids.
46. Domschke K., Dannlowski U., Hohoff C., Ohrmann P., Bauer J., Kugel H., Zwanzger P., Heindel W., Deckert J., Arolt V., Suslow T., Baune B.T. Neuropeptide Y (NPY) gene: Impact on emotional processing and treatment response in anxious depression. Eur. Neuropsychopharmacol. 2010, 20:301-309.
47. Dumont Y., Jacques D., Bouchard P., Quirion R. Species differences in the expression and distribution of the neuropeptide Y Y1, Y2, Y4, and Y5 receptors in rodents, guinea pig, and primates brains. J. Comp. Neurol. 1998, 402:372-384.
48. 125I]hPP) in the CNS: Enrichment in the area postrema. J. Mol. Neurosci. 2007, 33:294-304.
49. Dunn A.J., Swiergiel A.H., de Beaurepaire R. Cytokines as mediators of depression: What can we learn from animal studies?. Neurosci. Biobehav. Rev. 2005, 29:891-909.
50. DuPont A.W., DuPont H.L. The intestinal microbiota and chronic disorders of the gut. Nat. Rev. Gastroenterol. Hepatol. 2011, 8:523-531.
51. Eaton K., Sallee F.R., Sah R. Relevance of neuropeptide Y (NPY) in psychiatry. Curr. Top. Med. Chem. 2007, 7:1645-1659.
52. Edelsbrunner M.E., Herzog H., Holzer P. Evidence from knockout mice that peptide YY and neuropeptide Y enforce murine locomotion, exploration and ingestive behaviour in a circadian cycle- and gender-dependent manner. Behav. Brain Res. 2009, 203:97-107.
53. Edelsbrunner M.E., Painsipp E., Herzog H., Holzer P. Evidence from knockout mice for distinct implications of neuropeptide-Y Y2 and Y4 receptors in the circadian control of locomotion, exploration, water and food intake. Neuropeptides 2009, 43:491-497.
54. Ekblad E., Sundler F. Distribution of pancreatic polypeptide and peptide YY. Peptides 2002, 23:251-261.
55. El Karim I.A., Linden G.J., Orr D.F., Lundy F.T. Antimicrobial activity of neuropeptides against a range of micro-organisms from skin, oral, respiratory and gastrointestinal tract sites. J. Neuroimmunol. 2008, 200:11-16.
56. Elitsur Y., Luk G.D., Colberg M., Gesell M.S., Dosescu J., Moshier J.A. Neuropeptide Y (NPY) enhances proliferation of human colonic lamina propria lymphocytes. Neuropeptides 1994, 26:289-295.
57. El-Salhy M., Danielsson A., Stenling R., Grimelius L. Colonic endocrine cells in inflammatory bowel disease. J. Intern. Med. 1997, 242:413-419.
58. Ergene E., Dunbar J.C., Barraco R.A. Visceroendocrine responses elicited by neuropeptide Y in the nucleus tractus solitarius. Brain Res. Bull. 1993, 32:461-465.
59. Eva C., Serra M., Mele P., Panzica G., Oberto A. Physiology and gene regulation of the brain NPY Y1 receptor. Front. Neuroendocrinol. 2006, 27:308-339.
60. Feltrin K.L., Patterson M., Ghatei M.A., Bloom S.R., Meyer J.H., Horowitz M., Feinle-Bisset C. Effect of fatty acid chain length on suppression of ghrelin and stimulation of PYY, GLP-2 and PP secretion in healthy men. Peptides 2006, 27:1638-1643.
61. Fendt M., Bürki H., Imobersteg S., Lingenhöhl K., McAllister K.H., Orain D., Uzunov D.P., Chaperon F. Fear-reducing effects of intra-amygdala neuropeptide Y infusion in animal models of conditioned fear: An NPY Y1 receptor independent effect. Psychopharmacology (Berl.) 2009, 206:291-301.
62. Fetissov S.O., Kopp J., Hökfelt T. Distribution of NPY receptors in the hypothalamus. Neuropeptides 2004, 38:175-188.
63. Field B.C., Chaudhri O.B., Bloom S.R. Bowels control brain: Gut hormones and obesity. Nat. Rev. Endocrinol. 2010, 6:444-453.
64. Forbes S., Herzog H., Cox H. A role for neuropeptide Y in the gender-specific gastrointestinal, corticosterone and feeding responses to stress. Br. J. Pharmacol. 2012, 166:2307-2316.
65. Frenois F., Moreau M., O'Connor J., Lawson M., Micon C., Lestage J., Kelley K.W., Dantzer R., Castanon N. Lipopolysaccharide induces delayed FosB/DeltaFosB immunostaining within the mouse extended amygdala, hippocampus and hypothalamus, that parallel the expression of depressive-like behavior. Psychoneuroendocrinology 2007, 32:516-531.
66. Fu-Cheng X., Anini Y., Chariot J., Castex N., Galmiche J.P., Rozé C. Mechanisms of peptide YY release induced by an intraduodenal meal in rats: Neural regulation by proximal gut. Pflügers Arch. 1997, 433:571-579.
67. Fujimiya M., Inui A. Peptidergic regulation of gastrointestinal motility in rodents. Peptides 2000, 21:1565-1582.
68. Gakis G., Mueller M.H., Hahn J., Glatzle J., Grundy D., Kreis M.E. Neuronal activation in the nucleus of the solitary tract following jejunal lipopolysaccharide in the rat. Auton. Neurosci. 2009, 148:63-68.
69. Gareau M.G., Wine E., Rodrigues D.M., Cho J.H., Whary M.T., Philpott D.J., MacQueen G., Sherman P.M. Bacterial infection causes stress-induced memory dysfunction in mice. Gut 2011, 60:307-317.
70. Ghia J.E., Blennerhassett P., Deng Y., Verdu E.F., Khan W.I., Collins S.M. Reactivation of inflammatory bowel disease in a mouse model of depression. Gastroenterology 2009, 136:2280-2288.
71. Goehler L.E., Park S.M., Opitz N., Lyte M., Gaykema R.P.A. Campylobacter jejuni infection increases anxiety-like behavior in the holeboard: Possible anatomical substrates for viscerosensory modulation of exploratory behavior. Brain Behav. Immun. 2008, 22:354-366.
72. Graff L.A., Walker J.R., Bernstein C.N. Depression and anxiety in inflammatory bowel disease: A review of comorbidity and management. Inflamm. Bowel Dis. 2009, 15:1105-1118.
73. Grenham S., Clarke G., Cryan J.F., Dinan T.G. Brain-gut-microbe communication in health and disease. Front. Physiol. 2011, 2:94.
74. Gropp E., Shanabrough M., Borok E., Xu A.W., Janoschek R., Buch T., Plum L., Balthasar N., Hampel B., Waisman A., Barsh G.S., Horvath T.L., Brüning J.C. Agouti-related peptide-expressing neurons are mandatory for feeding. Nat. Neurosci. 2005, 8:1289-1291.
75. Guilloteau P., Martin L., Eeckhaut V., Ducatelle R., Zabielski R., Van Immerseel F. From the gut to the peripheral tissues: The multiple effects of butyrate. Nutr. Res. Rev. 2010, 23:366-384.
76. Gulec G., Isbil-Buyukcoskun N., Kahveci N. Effects of centrally-injected glucagon-like peptide-1 on pilocarpine-induced seizures, anxiety and locomotor and exploratory activity in rat. Neuropeptides 2010, 44:285-291.
77. Gustafson E.L., Smith K.E., Durkin M.M., Walker M.W., Gerald C., Weinshank R., Branchek T.A. Distribution of the neuropeptide Y Y2 receptor mRNA in rat central nervous system. Mol. Brain Res. 1997, 46:223-235.
78. Halldén G., Aponte G.W. Evidence for a role of the gut hormone PYY in the regulation of intestinal fatty acid-binding protein transcripts in differentiated subpopulations of intestinal epithelial cell hybrids. J. Biol. Chem. 1997, 272:12591-12600.
79. Hassani H., Lucas G., Rozell B., Ernfors P. Attenuation of acute experimental colitis by preventing NPY Y1 receptor signaling. Am. J. Physiol. 2005, 288:G550-G556.
80. Heijtz R.D., Wang S., Anuar F., Qian Y., Björkholm B., Samuelsson A., Hibberd M.L., Forssberg H., Pettersson S. Normal gut microbiota modulates brain development and behavior. Proc. Natl. Acad. Sci. USA 2011, 108:3047-3052.
81. Heilig M. The NPY system in stress, anxiety and depression. Neuropeptides 2004, 38:213-224.
82. Heilig M., Söderpalm B., Engel J.A., Widerlöv E. Centrally administered neuropeptide Y (NPY) produces anxiolytic-like effects in animal anxiety models. Psychopharmacology (Berl.) 1989, 98:524-529.
83. Hendriksen H., Bink D.I., Daniels E.G., Pandit R., Piriou C., Slieker R., Westphal K.G., Olivier B., Oosting R.S. Re-exposure and environmental enrichment reveal NPY-Y1 as a possible target for post-traumatic stress disorder. Neuropharmacology 2012, 63:733-742.
84. Hernanz A., Tato E., De la Fuente M., de Miguel E., Arnalich F. Differential effects of gastrin-releasing peptide, neuropeptide Y, somatostatin and vasoactive intestinal peptide on interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha production by whole blood cells from healthy young and old subjects. J. Neuroimmunol. 1996, 71:25-30.
85. Hirotani Y., Mikajiri K., Ikeda K., Myotoku M., Kurokawa N. Changes of the peptide YY levels in the intestinal tissue of rats with experimental colitis following oral administration of mesalazine and prednisolone. Yakugaku Zasshi 2008, 128:1347-1353.
86. Hirsch D., Zukowska Z. NPY and stress 30 years later: The peripheral view. Cell. Mol. Neurobiol. 2012, 32:645-659.
87. Holzer P. Neural regulation of gastrointestinal blood flow. Physiology of the Gastrointestinal Tract 2012, 817-845. Academic Press, Oxford. 5th ed. L.R. Johnson (Ed.).
88. Holzer P., Holzer-Petsche U. Pharmacology of inflammatory pain: Local alteration in receptors and mediators. Dig. Dis. 2009, 27(Suppl. 1):24-30.
89. Holzer P., Barthó L., Lippe I.T., Petritsch W., Leb G. Effect of pancreatic polypeptide on the motility of the guinea-pig small intestine in vitro. Regul. Pept. 1986, 16:305-314.
90. Holzer P., Lippe I.T., Barthó L., Saria A. Neuropeptide Y inhibits excitatory enteric neurons supplying the circular muscle of the guinea pig small intestine. Gastroenterology 1987, 92:1944-1950.
91. Holzer P., Schicho R., Holzer-Petsche U., Lippe I.T. The gut as a neurological organ. Wien. Klin. Wochenschr. 2001, 113:647-660.
92. Holzer P., Danzer M., Schicho R., Samberger C., Painsipp E., Lippe I.T. Vagal afferent input from the acid-challenged rat stomach to the brainstem: Enhancement by interleukin-1β. Neuroscience 2004, 129:439-445.
93. Holzer-Petsche U., Petritsch W., Hinterleitner T., Eherer A., Sperk G., Krejs G.J. Effect of neuropeptide Y on jejunal water and ion transport in humans. Gastroenterology 1991, 101:325-330.
94. Hubel K.A., Renquist K.S. Effect of neuropeptide Y on ion transport by the rabbit ileum. J. Pharmacol. Exp. Ther. 1986, 238:167-169.
95. Hughes P.A., Brierley S.M., Blackshaw L.A. Post-inflammatory modification of colonic afferent mechanosensitivity. Clin. Exp. Pharmacol. Physiol. 2009, 36:1034-1040.
96. Inui A., Okita M., Miura M., Hirosue Y., Mizuno N., Baba S., Kasuga M. Plasma and cerebroventricular fluid levels of pancreatic polypeptide in the dog: Effects of feeding, insulin-induced hypoglycemia, and physical exercise. Endocrinology 1993, 132:1235-1239.
97. Iwai T., Hayashi Y., Narita S., Kasuya Y., Jin K., Tsugane M., Oka J. Antidepressant-like effects of glucagon-like peptide-2 in mice occur via monoamine pathways. Behav. Brain Res. 2009, 204:235-240.
98. 2 receptors in the regulation of gastric tone in rats. Am. J. Physiol. 2012, 302:G732-G739.
99. Jeffery I.B., O'Toole P.W., Ohman L., Claesson M.J., Deane J., Quigley E.M., Simrén M. An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota. Gut 2012, 61:997-1006.
100. Ji R.R., Zhang X., Wiesenfeld-Hallin Z., Hökfelt T. Expression of neuropeptide Y and neuropeptide Y (Y1) receptor mRNA in rat spinal cord and dorsal root ganglia following peripheral tissue inflammation. J. Neurosci. 1994, 14:6423-6434.
101. Karl T., Burne T.H., Herzog H. Effect of Y1 receptor deficiency on motor activity, exploration, and anxiety. Behav. Brain Res. 2006, 167:87-93.
102. Karl T., Duffy L., Herzog H. Behavioural profile of a new mouse model for NPY deficiency. Eur. J. Neurosci. 2008, 28:173-180.
103. Karlsson R.M., Holmes A., Heilig M., Crawley J.N. Anxiolytic-like actions of centrally-administered neuropeptide Y, but not galanin, in C57BL/6J mice. Pharmacol. Biochem. Behav. 2005, 80:427-436.
104. Kask A., Harro J., von Hörsten S., Redrobe J.P., Dumont Y., Quirion R. The neurocircuitry and receptor subtypes mediating anxiolytic-like effects of neuropeptide Y. Neurosci. Biobehav. Rev. 2002, 26:259-283.
105. Kinzig K.P., D'Alessio D.A., Herman J.P., Sakai R.R., Vahl T.P., Figueiredo H.F., Murphy E.K., Seeley R.J. CNS glucagon-like peptide-1 receptors mediate endocrine and anxiety responses to interoceptive and psychogenic stressors. J. Neurosci. 2003, 23:6163-6170.
106. Kirchner H., Tong J., Tschöp M.H., Pfluger P.T. Ghrelin and PYY in the regulation of energy balance and metabolism: Lessons from mouse mutants. Am. J. Physiol. 2010, 298:E909-E919.
107. Klompus M., Ho W., Sharkey K.A., McKay D.M. Antisecretory effects of neuropeptide Y in the mouse colon are region-specific and are lost in DSS-induced colitis. Regul. Pept. 2010, 165:138-145.
108. Knowles C.H., Aziz Q. Basic and clinical aspects of gastrointestinal pain. Pain 2009, 141:191-209.
109. 3-36-induced feeding reduction in rats. Endocrinology 2005, 146:2369-2375.
110. Kopp J., Xu Z.Q., Zhang X., Pedrazzini T., Herzog H., Kresse A., Wong H., Walsh J.H., Hökfelt T. Expression of the neuropeptide Y Y1 receptor in the CNS of rat and of wild-type and Y1 receptor knock-out mice. Focus on immunohistochemical localization. Neuroscience 2002, 111:443-532.
111. Krogius-Kurikka L., Lyra A., Malinen E., Aarnikunnas J., Tuimala J., Paulin L., Mäkivuokko H., Kajander K., Palva A. Microbial community analysis reveals high level phylogenetic alterations in the overall gastrointestinal microbiota of diarrhoea-predominant irritable bowel syndrome sufferers. BMC Gastroenterol. 2009, 9:95.
112. Lamb K., Kang Y.M., Gebhart G.F., Bielefeldt K. Gastric inflammation triggers hypersensitivity to acid in awake rats. Gastroenterology 2003, 125:1410-1418.
113. Larsen P.J., Kristensen P. The neuropeptide Y Y4 receptor is highly expressed in neurones of the rat dorsal vagal complex. Mol. Brain Res. 1997, 48:1-6.
114. Lawrence A.J., Castillo-Melendez M., McLean K.J., Jarrott B. The distribution of nitric oxide synthase-, adenosine deaminase- and neuropeptide Y-immunoreactivity through the entire rat nucleus tractus solitarius: Effect of unilateral nodose ganglionectomy. J. Chem. Neuroanat. 1998, 15:27-40.
115. Levy R.L., Olden K.W., Naliboff B.D., Bradley L.A., Francisconi C., Drossman D.A., Creed F. Psychosocial aspects of the functional gastrointestinal disorders. Gastroenterology 2006, 130:1447-1458.
116. Liang C., Luo H., Liu Y., Cao J., Xia H. Plasma hormones facilitated the hypermotility of the colon in a chronic stress rat model. PLoS One 2012, 7:e31774.
117. Lin H.C., Zhao X.T., Wang L., Wong H. Fat-induced ileal brake in the dog depends on PYY. Gastroenterology 1996, 110:1491-1495.
118. Lomax A.E., Sharkey K.A., Furness J.B. The participation of the sympathetic innervation of the gastrointestinal tract in disease states. Neurogastroenterol. Motil. 2010, 22:7-18.
119. Longstreth G.F., Thompson W.G., Chey W.D., Houghton L.A., Mearin F., Spiller R.C. Functional bowel disorders. Gastroenterology 2006, 130:1480-1491.
120. Luquet S., Perez F.A., Hnasko T.S., Palmiter R.D. NPY/AgRP neurons are essential for feeding in adult mice but can be ablated in neonates. Science 2005, 310:683-685.
121. Lutter M., Sakata I., Osborne-Lawrence S., Rovinsky S.A., Anderson J.G., Jung S., Birnbaum S., Yanagisawa M., Elmquist J.K., Nestler E.J., Zigman J.M. The orexigenic hormone ghrelin defends against depressive symptoms of chronic stress. Nat. Neurosci. 2008, 11:752-753.
122. Macia L., Thorburn A.N., Binge L.C., Marino E., Rogers K.E., Maslowski K.M., Vieira A.T., Kranich J., Mackay C.R. Microbial influences on epithelial integrity and immune function as a basis for inflammatory diseases. Immunol. Rev. 2012, 245:164-176.
123. Maes M., Yirmyia R., Noraberg J., Brene S., Hibbeln J., Perini G., Kubera M., Bob P., Lerer B., Maj M. The inflammatory & neurodegenerative (I&ND) hypothesis of depression: Leads for future research and new drug developments in depression. Metab. Brain Dis. 2009, 24:27-53.
124. Maes M., Kubera M., Leunis J.C., Berk M. Increased IgA and IgM responses against gut commensals in chronic depression: Further evidence for increased bacterial translocation or leaky gut. J. Affect. Disord. 2012, 141:55-62.
125. Mawdsley J.E., Rampton D.S. Psychological stress in IBD: New insights into pathogenic and therapeutic implications. Gut 2005, 54:1481-1491.
126. Mayer E.A., Bradesi S., Chang L., Spiegel B.M., Bueller J.A., Naliboff B.D. Functional GI disorders: From animal models to drug development. Gut 2008, 57:384-404.
127. McCarthy H.D., Dryden S., Williams G. Interleukin-1β-induced anorexia and pyrexia in rat: Relationship to hypothalamic neuropeptide Y. Am. J. Physiol. 1995, 269:E852-E857.
128. McEwen B.S. Physiology and neurobiology of stress and adaptation: Central role of the brain. Physiol. Rev. 2007, 87:873-904.
129. McGowan B.M.C., Bloom S.R. Peptide YY and appetite control. Curr. Opin. Pharmacol. 2004, 4:583-588.
130. McGuire J.L., Larke L.E., Sallee F.R., Herman J.P., Sah R. Differential regulation of neuropeptide Y in the amygdala and prefrontal cortex during recovery from chronic variable stress. Front. Behav. Neurosci. 2011, 5:54.
131. McKernan D.P., Gaszner G., Quigley E.M., Cryan J.F., Dinan T.G. Altered peripheral toll-like receptor responses in the irritable bowel syndrome. Aliment. Pharmacol. Ther. 2011, 33:1045-1052.
132. McMahon C.D., Buxton D.F., Elsasser T.H., Gunter D.R., Sanders L.G., Steele B.P., Sartin J.L. Neuropeptide Y restores appetite and alters concentrations of GH after central administration to endotoxic sheep. J. Endocrinol. 1999, 161:333-339.
133. Medeiros M.D., Turner A.J. Processing and metabolism of peptide-YY: Pivotal roles of dipeptidylpeptidase-IV, aminopeptidase-P, and endopeptidase-24.11. Endocrinology 1994, 134:2088-2094.
134. Mele P., Oberto A., Serra M., Pisu M.G., Floris I., Biggio G., Eva C. Increased expression of the gene for the Y1 receptor of neuropeptide Y in the amygdala and paraventricular nucleus of Y1R/LacZ transgenic mice in response to restraint stress. J. Neurochem. 2004, 89:1471-1478.
135. Melgar S., Shanahan F. Inflammatory bowel disease - From mechanisms to treatment strategies. Autoimmunity 2010, 43:463-477.
136. Mentlein R., Dahms P., Grandt D., Krüger R. Proteolytic processing of neuropeptide Y and peptide YY by dipeptidyl peptidase IV. Regul. Pept. 1993, 49:133-144.
137. Mickey B.J., Zhou Z., Heitzeg M.M., Heinz E., Hodgkinson C.A., Hsu D.T., Langenecker S.A., Love T.M., Peciña M., Shafir T., Stohler C.S., Goldman D., Zubieta J.K. Emotion processing, major depression, and functional genetic variation of neuropeptide Y. Arch. Gen. Psychiatry 2011, 68:158-166.
138. Mitić K., Stanojević S., Kuštrimović N., Vujić V., Dimitrijević M. Neuropeptide Y modulates functions of inflammatory cells in the rat: Distinct role for Y1, Y2 and Y5 receptors. Peptides 2011, 32:1626-1633.
139. Mittermaier C., Dejaco C., Waldhoer T., Oefferlbauer-Ernst A., Miehsler W., Beier M., Tillinger W., Gangl A., Moser G. Impact of depressive mood on relapse in patients with inflammatory bowel disease: A prospective 18-month follow-up study. Psychosom. Med. 2004, 66:79-84.
140. Möller C., Sommer W., Thorsell A., Rimondini R., Heilig M. Anxiogenic-like action of centrally administered glucagon-like peptide-1 in a punished drinking test. Prog. Neuropsychopharmacol. Biol. Psychiatry 2002, 26:119-122.
141. Morales-Medina J.C., Dumont Y., Quirion R. A possible role of neuropeptide Y in depression and stress. Brain Res. 2010, 1314:194-205.
142. Moreau M., André C., O'Connor J.C., Dumich S.A., Woods J.A., Kelley K.W., Dantzer R., Lestage J., Castanon N. Inoculation of Bacillus Calmette-Guerin to mice induces an acute episode of sickness behavior followed by chronic depressive-like behavior. Brain Behav. Immun. 2008, 22:1087-1095.
143. Morgan C.A., Rasmusson A.M., Winters B., Hauger R.L., Morgan J., Hazlett G., Southwick S. Trauma exposure rather than posttraumatic stress disorder is associated with reduced baseline plasma neuropeptide-Y levels. Biol. Psychiatry 2003, 54:1087-1091.
144. Morimoto R., Satoh F., Murakami O., Totsune K., Saruta M., Suzuki T., Sasano H., Ito S., Takahashi K. Expression of peptide YY in human brain and pituitary tissues. Nutrition 2008, 24:878-884.
145. Murphy K.G., Bloom S.R. Gut hormones and the regulation of energy homeostasis. Nature 2006, 444:854-859.
146. Naveilhan P., Hassani H., Lucas G., Blakeman K.H., Hao J.X., Xu X.J., Wiesenfeld-Hallin Z., Thorén P., Ernfors P. Reduced antinociception and plasma extravasation in mice lacking a neuropeptide Y receptor. Nature 2001, 409:513-517.
147. Nicholl B.I., Halder S.L., Macfarlane G.J., Thompson D.G., O'Brien S., Musleh M., McBeth J. Psychosocial risk markers for new onset irritable bowel syndrome - Results of a large prospective population-based study. Pain 2008, 137:147-155.
148. Nightingale J.M.D., Kamm M.A., van der Sijp J.R.M., Ghatei M.A., Bloom S.R., Lennard-Jones J.E. Gastrointestinal hormones in short bowel syndrome. PYY may be the colonic brake to gastric emptying. Gut 1996, 39:267-272.
149. 3-36 in the mouse. J. Pharmacol. Exp. Ther. 2003, 306:948-953.
150. Painsipp E., Wultsch T., Shahbazian A., Edelsbrunner M., Kreissl M.C., Schirbel A., Bock E., Pabst M.A., Thoeringer C.K., Huber H.P., Holzer P. Experimental gastritis in mice enhances anxiety in a gender-related manner. Neuroscience 2007, 150:522-536.
151. Painsipp E., Herzog H., Holzer P. Implication of neuropeptide-Y Y2 receptors in the effects of immune stress on emotional, locomotor and social behavior of mice. Neuropharmacology 2008, 55:117-126.
152. Painsipp E., Wultsch T., Edelsbrunner M.E., Tasan R.O., Singewald N., Herzog H., Holzer P. Reduced anxiety-like and depression-related behavior in neuropeptide Y Y4 receptor knockout mice. Genes Brain Behav. 2008, 7:532-542.
153. Painsipp E., Herzog H., Holzer P. Evidence from knockout mice that neuropeptide-Y Y2 and Y4 receptor signalling prevents long-term depression-like behavior caused by immune challenge. J. Psychopharmacol. 2010, 24:1551-1560.
154. Painsipp E., Sperk G., Herzog H., Holzer P. Delayed stress-induced differences in locomotor and depression-related behaviour in female neuropeptide-Y Y1 receptor knockout mice. J. Psychopharmacol. 2010, 24:1541-1549.
155. Painsipp E., Herzog H., Sperk G., Holzer P. Sex-dependent control of murine emotional-affective behaviour in health and colitis by peptide YY and neuropeptide Y. Br. J. Pharmacol. 2011, 163:1302-1314.
156. Painsipp E., Köfer M.J., Sinner F., Holzer P. Prolonged depression-like behavior caused by immune challenge: Influence of mouse strain and social environment. PLoS One 2011, 6:e20719.
157. Painsipp, E., Köfer, M.J., Dischinger, U.S., Sinner, F., Sperk, G., Herzog, H., Holzer, P., submitted for publication. Neuropeptide Y and peptide YY participate in the sickness and behavioural disturbance caused by Bacille Calmette-Guérin. PLoS One.
158. Pang X.H., Li T.K., Xie Q., He F.Q., Cui D.J., Chen Y.Q., Huang X.L., Gan H.T. Amelioration of dextran sulfate sodium-induced colitis by neuropeptide Y antisense oligodeoxynucleotide. Int. J. Colorectal Dis. 2010, 25:1047-1053.
159. Parker R.M., Herzog H. Regional distribution of Y-receptor subtype mRNAs in rat brain. Eur. J. Neurosci. 1999, 11:1431-1448.
160. Pironi L., Stanghellini V., Miglioli M., Corinaldesi R., De Giorgio R., Ruggeri E., Tosetti C., Poggioli G., Morselli Labate A.M., Monetti N., Gozzetti G., Barbara L., Go V.L.W. Fat-induced ileal brake in humans: A dose-dependent phenomenon correlated to the plasma levels of PYY. Gastroenterology 1993, 105:733-739.
161. Primeaux S.D., Wilson S.P., Cusick M.C., York D.A., Wilson M.A. Effects of altered amygdalar neuropeptide Y expression on anxiety-related behaviors. Neuropsychopharmacology 2005, 30:1589-1597.
162. Pyter L.M., Pineros V., Galang J.A., McClintock M.K., Prendergast B.J. Peripheral tumors induce depressive-like behaviors and cytokine production and alter hypothalamic-pituitary-adrenal axis regulation. Proc. Natl. Acad. Sci. USA 2009, 106:9069-9074.
163. Raison C.L., Capuron L., Miller A.H. Cytokines sing the blues: Inflammation and the pathogenesis of depression. Trends Immunol. 2006, 27:24-31.
164. Redrobe J.P., Dumont Y., Herzog H., Quirion R. Neuropeptide Y (NPY) Y2 receptors mediate behaviour in two animal models of anxiety: Evidence from Y2 receptor knockout mice. Behav. Brain Res. 2003, 141:251-255.
165. Redrobe J.P., Carvajal C., Kask A., Dumont Y., Quirion R. Neuropeptide Y and its receptor subtypes in the central nervous system: Emphasis on their role in animal models of psychiatric disorders. Handb. Exp. Pharmacol. 2004, 162:101-136.
166. Redrobe J.P., Dumont Y., Herzog H., Quirion R. Characterization of neuropeptide Y, Y2 receptor knockout mice in two animal models of learning and memory processing. J. Mol. Neurosci. 2004, 22:159-166.
167. Rozengurt N., Wu S.V., Chen M.C., Huang C., Sternini C., Rozengurt E. Co-localisation of the α subunit of gustducin with PYY and GLP-1 in L-cells of human colon. Am. J. Physiol. 2006, 291:G792-G802.
168. Sah R., Ekhator N.N., Strawn J.R., Sallee F.R., Baker D.G., Horn P.S., Geracioti T.D. Low cerebrospinal fluid neuropeptide Y concentrations in posttraumatic stress disorder. Biol. Psychiatry 2009, 66:705-707.
169. Sainsbury A., Schwarzer C., Couzens M., Jenkins A., Oakes S.R., Ormandy C.J., Herzog H. Y4 receptor knockout rescues fertility in ob/ob mice. Genes Dev. 2002, 16:1077-1088.
170. Sajdyk T.J., Johnson P.L., Leitermann R.J., Fitz S.D., Dietrich A., Morin M., Gehlert D.R., Urban J.H., Shekhar A. Neuropeptide Y in the amygdala induces long-term resilience to stress-induced reductions in social responses but not hypothalamic-adrenal-pituitary axis activity or hyperthermia. J. Neurosci. 2008, 28:893-903.
171. Samuel B.S., Shaito A., Motoike T., Rey F.E., Backhed F., Manchester J.K., Hammer R.E., Williams S.C., Crowley J., Yanagisawa M., Gordon J.I. Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41. Proc. Natl. Acad. Sci. USA 2008, 105:16767-16772.
172. Saria A., Beubler E. Neuropeptide Y (NPY) and peptide YY (PYY) inhibit prostaglandin E2-induced intestinal fluid and electrolyte secretion in the rat jejunum in vivo. Eur. J. Pharmacol. 1985, 119:47-52.
173. Schicho R., Schemann M., Pabst M.A., Holzer P., Lippe I.T. Capsaicin-sensitive extrinsic afferents are involved in acid-induced activation of distinct myenteric neurons in the rat stomach. Neurogastroenterol. Motil. 2003, 15:33-44.
174. Schmidt P.T., Ljung T., Hartmann B., Hare K.J., Holst J.J., Hellström P.M. Tissue levels and post-prandial secretion of the intestinal growth factor, glucagon-like peptide-2, in controls and inflammatory bowel disease: Comparison with peptide YY. Eur. J. Gastroenterol. Hepatol. 2005, 17:207-712.
175. Schuligoi R., Jocic M., Heinemann A., Schöninkle E., Pabst M.A., Holzer P. Gastric acid-evoked c-fos messenger RNA expression in rat brainstem is signaled by capsaicin-resistant vagal afferents. Gastroenterology 1998, 115:649-660.
176. Schwartz T.W. Pancreatic polypeptide: A unique model for vagal control of endocrine systems. J. Auton. Nerv. Syst. 1983, 9:99-111.
177. Shanahan F. The colonic microflora and probiotic therapy in health and disease. Curr. Opin. Gastroenterol. 2011, 27:61-65.
178. Shi T.J., Li J., Dahlström A., Theodorsson E., Ceccatelli S., Decosterd I., Pedrazzini T., Hökfelt T. Deletion of the neuropeptide Y Y1 receptor affects pain sensitivity, neuropeptide transport and expression, and dorsal root ganglion neuron numbers. Neuroscience 2006, 140:293-304.
179. Shibata M., Hisajima T., Nakano M., Goris R.C., Funakoshi K. Morphological relationships between peptidergic nerve fibers and immunoglobulin A-producing lymphocytes in the mouse intestine. Brain Behav. Immun. 2008, 22:158-166.
180. 3-36 in the treatment of obesity. Expert Opin. Investig. Drugs 2005, 14:647-653.
181. Smith P.A., Moran T.D., Abdulla F., Tumber K.K., Taylor B.K. Spinal mechanisms of NPY analgesia. Peptides 2007, 28:464-474.
182. Solway B., Bose S.C., Corder G., Donahue R.R., Taylor B.K. Tonic inhibition of chronic pain by neuropeptide Y. Proc. Natl. Acad. Sci. USA 2011, 108:7224-7229.
183. Sonti G., Ilyin S.E., Plata-Salaman C.R. Neuropeptide Y blocks and reverses interleukin-1β-induced anorexia in rats. Peptides 1996, 17:517-520.
184. Sørensen G., Lindberg C., Wörtwein G., Bolwig T.G., Woldbye D.P. Differential roles for neuropeptide Y Y1 and Y5 receptors in anxiety and sedation. J. Neurosci. Res. 2004, 77:723-729.
185. Spiller R., Garsed K. Postinfectious irritable bowel syndrome. Gastroenterology 2009, 136:1979-1988.
186. Straub R.H., Herfarth H., Falk W., Andus T., Schölmerich J. Uncoupling of the sympathetic nervous system and the hypothalamic-pituitary-adrenal axis in inflammatory bowel disease?. J. Neuroimmunol. 2002, 126:116-125.
187. Taché Y., Bernstein C.N. Evidence for the role of the brain-gut axis in inflammatory bowel disease: Depression as cause and effect?. Gastroenterology 2009, 136:2058-2061.
188. Tana C., Umesaki Y., Imaoka A., Handa T., Kanazawa M., Fukudo S. Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome. Neurogastroenterol. Motil. 2010, 22:512-519.
189. Tari A., Teshima H., Sumii K., Haruma K., Ohgoshi H., Yoshihara M., Kajiyama G., Miyachi Y. Peptide YY abnormalities in patients with ulcerative colitis. Jpn. J. Med. 1988, 27:49-55.
190. Tasan R.O., Lin S., Hetzenauer A., Singewald N., Herzog H., Sperk G. Increased novelty-induced motor activity and reduced depression-like behavior in neuropeptide Y (NPY)-Y4 receptor knockout mice. Neuroscience 2009, 158:1717-1730.
191. Tasan R.O., Nguyen N.K., Weger S., Sartori S.B., Singewald N., Heilbronn R., Herzog H., Sperk G. The central and basolateral amygdala are critical sites of neuropeptide Y/Y2 receptor-mediated regulation of anxiety and depression. J. Neurosci. 2010, 30:6282-6290.
192. Thorsell A., Svensson P., Wiklund L., Sommer W., Ekman R., Heilig M. Suppressed neuropeptide Y (NPY) mRNA in rat amygdala following restraint stress. Regul. Pept. 1998, 75-76:247-254.
193. Thorsell A., Carlsson K., Ekman R., Heilig M. Behavioral and endocrine adaptation, and up-regulation of NPY expression in rat amygdala following repeated restraint stress. Neuroreport 1999, 10:3003-3007.
194. Thorsell A., Michalkiewicz M., Dumont Y., Quirion R., Caberlotto L., Rimondini R., Mathé A.A., Heilig M. Behavioral insensitivity to restraint stress, absent fear suppression of behavior and impaired spatial learning in transgenic rats with hippocampal neuropeptide Y overexpression. Proc. Natl. Acad. Sci. USA 2000, 97:12852-12857.
195. 4 receptors mediate the inhibitory responses of pancreatic polypeptide in human and mouse colon mucosa. J. Pharmacol. Exp. Ther. 2006, 319:20-30.
196. 2 receptors. Br. J. Pharmacol. 2011, 164:471-484.
197. Tschenett A., Singewald N., Carli M., Balducci C., Salchner P., Vezzani A., Herzog H., Sperk G. Reduced anxiety and improved stress coping ability in mice lacking NPY-Y2 receptors. Eur. J. Neurosci. 2003, 18:143-148.
198. Ueno N., Inui A., Iwamoto M., Kaga T., Asakawa A., Okita M., Fujimiya M., Nakajima Y., Ohmoto Y., Ohnaka M., Nakaya Y., Miyazaki J.I., Kasuga M. Decreased food intake and body weight in pancreatic polypeptide-overexpressing mice. Gastroenterology 1999, 117:1427-1432.
199. Ueno N., Asakawa A., Satoh Y., Inui A. Increased circulating cholecystokinin contributes to anorexia and anxiety behavior in mice overexpressing pancreatic polypeptide. Regul. Pept. 2007, 141:8-11.
200. Ueno H., Yamaguchi H., Mizuta M., Nakazato M. The role of PYY in feeding regulation. Regul. Pept. 2008, 145:12-16.
201. Van Citters G.W., Lin H.C. Ileal brake: Neuropeptidergic control of intestinal transit. Curr. Gastroenterol. Rep. 2006, 8:367-373.
202. Wang L., Gourcerol G., Yuan P.Q., Wu S.V., Million M., Larauche M., Taché Y. Peripheral peptide YY inhibits propulsive colonic motor function through Y2 receptor in conscious mice. Am. J. Physiol. 2010, 298:G45-G56.
203. Wettstein J.G., Earley B., Junien J.L. Central nervous system pharmacology of neuropeptide Y. Pharmacol. Ther. 1995, 65:397-414.
204. Wheway J., Mackay C.R., Newton R.A., Sainsbury A., Boey D., Herzog H., Mackay F. A fundamental bimodal role for neuropeptide Y1 receptor in the immune system. J. Exp. Med. 2005, 202:1527-1538.
205. Wheway J., Herzog H., Mackay F. NPY and receptors in immune and inflammatory diseases. Curr. Top. Med. Chem. 2007, 7:1743-1752.
206. Wheway J., Herzog H., Mackay F. The Y1 receptor for NPY: A key modulator of the adaptive immune system. Peptides 2007, 28:453-458.
207. Wittig B.M., Zeitz M. The gut as an organ of immunology. Int. J. Colorectal. Dis. 2003, 18:181-187.
208. Wolak M.L., DeJoseph M.R., Cator A.D., Mokashi A.S., Brownfield M.S., Urban J.H. Comparative distribution of neuropeptide Y Y1 and Y5 receptors in the rat brain by using immunohistochemistry. J. Comp. Neurol. 2003, 464:285-311.
209. Wultsch T., Painsipp E., Thoeringer C.K., Herzog H., Sperk G., Holzer P. Endogenous neuropeptide Y depresses the afferent signaling of gastric acid challenge to the mouse brainstem via neuropeptide Y type Y2 and Y4 receptors. Neuroscience 2005, 136:1097-1107.
210. Yang H. Central and peripheral regulation of gastric acid secretion by peptide YY. Peptides 2002, 23:349-358.
211. Yang H., Kawakubo K., Tache Y. Intracisternal PYY increases gastric mucosal resistance: Role of cholinergic, CGRP, and NO pathways. Am. J. Physiol. 1999, 277:G555-G562.
212. Yehuda R., Brand S., Yang R.K. Plasma neuropeptide Y concentrations in combat exposed veterans: Relationship to trauma exposure, recovery from PTSD, and coping. Biol. Psychiatry 2006, 59:660-663.
213. Yirmiya R. Endotoxin produces a depressive-like episode in rats. Brain Res. 1996, 711:163-174.
214. Zhang X., Shi T., Holmberg K., Landry M., Huang W., Xiao H., Ju G., Hökfelt T. Expression and regulation of the neuropeptide Y Y2 receptor in sensory and autonomic ganglia. Proc. Natl. Acad. Sci. USA 1997, 94:729-734.
215. Zhang L., Bijker M.S., Herzog H. The neuropeptide Y system: Pathophysiological and therapeutic implications in obesity and cancer. Pharmacol. Ther. 2011, 131:91-113.
216. Zhou Z., Zhu G., Hariri A.R., Enoch M., Scott D., Sinha R., Virkkunen M., Mash D.C., Lipsky R.H., Hu X.Z., Hodgkinson C.A., Xu K., Buzas B., Yuan Q., Shen P.H., Ferrell R.E., Manuck S.B., Brown S.M., Hauger R.L., Stohler C.S., Zubieta J.K., Goldman D. Genetic variation in human NPY expression affects stress response and emotion. Nature 2008, 452:997-1001.